Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-024422
Filing Date
2021-02-16
Accepted
2021-02-16 17:29:06
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm216714-4_5seq1.html 5  
1 OWNERSHIP DOCUMENT tm216714-4_5seq1.xml 5 8241
  Complete submission text file 0001104659-21-024422.txt   9602
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 EAST MAIN STREET C/O BIOXCEL THERAPEUTICS, INC. BRANFORD CT 06405
Business Address
Mehta Vimal (Reporting) CIK: 0001733369 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-38410 | Film No.: 21641156